45
Views
7
CrossRef citations to date
0
Altmetric
Research Article

Protective colloids and polylactic acid co-affecting the polymorphic crystal forms and crystallinity of indomethacin encapsulated in microspheres

Pages 769-776 | Published online: 29 Sep 2008

References

  • ABDOU, H. M. (ed.), 1989, Effect of the physicochemical properties of the drug on dissolution. In Dissolution, Bioavailability and Bioequivalence (Easton: Mack Pub. Co.), pp. 53–72.
  • BAKER, R., 1987, Biodegradable systems. In Controlled Release of Biologically Active Agents, edited by R. Baker (New York John Wiley & Sons), pp. 84–131.
  • BCRKA, L., 1974, The polymorphism of indomethacin. Acta Pharm. Suec., 11, 295–303.
  • DUBEMET, C., ROULAND J. C., and BENUT, J. P., 1991, Ibuprofen-loaded ethylcellulose microspheres: Analysis of the matrix structure by thermal analysis. Journal of Pharmaceutical Science, 80, 1029–1033.
  • FONG J. W., 1988, Microencapsulation by solvent evaporation and organic phase separation processes. In Controlled Release Systems. Fabrication Technology, Vol. I, edited by D. Hsieh (Boca Raton: CRC Press), pp. 81–108.
  • IMAIZUM, H., NAMBU N., and NAGAI, T., 1980, Stability and several physical properties of amorphous and crystalline forms of indomethacin. Chemical Pharmaceutical Bulletin, 28, 2565–2569.
  • KANENIWA, N., orsum, M, and HAYASHI T., 1985, Physicochemical characterization of indomethacin polymorphs and the transformation kinetics in ethanol. Chemical Pharmaceutical Bulletin, 33,3447–3455.
  • LIN S. Y., 1992, Islation and solid-state characteristics of a new crystal form of indomethacin Journal of Pharmaceutical Science, 81, 572–576.
  • LIN S. Y., and CHERNG J. Y., 1995, Polymorphic transformation of indomethacin in Procirol solid dispersion system. Journal of Thermal Analysis, 45, 1565–1577.
  • LIN S. Y., and PERNG R. I., 1993, Solid-state interaction studies of drug/polymers I. Indomethacin/Eudragit E, RL or S resins. ST. Pharma Science, 3, 465–471.
  • LIN S. Y., GHENT K. S., and TENG H H, 1998a, Functionality of protective colloids affecting the formation, size uniformity and morphology of drug-free polylactic acid microspheres. Journal of Microencapsulation, 15, 383–390.
  • LIN S. Y., CHEN K. S., and TENG H. H, 1999, Effect of protective colloids on the induction of polymorphic changes in indomethacin agglomerates after solvent evaporation from o/w emulsions. Journal of Micorencapsulation, 16, 38–47.
  • LIN S. Y., HQ L. T., and CHIOU H L., 1985, Microencapsulation and controlled release of insulin from polylactic acid microcapsules. Biomaterials & Medical Development in Artificial Organs, 13, 187–201.
  • LIN S. Y., HQ L. T., and CHIOU H L., 1988, Insulin controlled-release microcapsules to prolong the hypoglycemic effect in diabetic rats. Biomaterials & Artificial Cell Artificial Organs, 16, 815–828.
  • LIN S. Y., TzAN Y. L., WEN C. N, and LEE, C. J., 1991, Preparation of enteric-coated microspheres of Mycoplasma hopneumoniae vaccine with cellulose acetate phthalate. I. Formation condition and micromeritic properties. Journal of Microencapsulation, 8, 317–325.
  • MONKHOUSE, D. C., and LACH J. L., 1972, Use of adsorbents in enhancement of drug dissolution. Journal of Pharmaceutical Science, 61, 1435–1441.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.